Rakotomalala, A.; Bailleul, Q.; Savary, C.; Arcicasa, M.; Hamadou, M.; Huchedé, P.; Hochart, A.; Restouin, A.; Castellano, R.; Collette, Y.;
et al. H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines. Cancers 2021, 13, 5551.
https://doi.org/10.3390/cancers13215551
AMA Style
Rakotomalala A, Bailleul Q, Savary C, Arcicasa M, Hamadou M, Huchedé P, Hochart A, Restouin A, Castellano R, Collette Y,
et al. H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines. Cancers. 2021; 13(21):5551.
https://doi.org/10.3390/cancers13215551
Chicago/Turabian Style
Rakotomalala, Andria, Quentin Bailleul, Clara Savary, Mélanie Arcicasa, Maud Hamadou, Paul Huchedé, Audrey Hochart, Audrey Restouin, Remy Castellano, Yves Collette,
and et al. 2021. "H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines" Cancers 13, no. 21: 5551.
https://doi.org/10.3390/cancers13215551
APA Style
Rakotomalala, A., Bailleul, Q., Savary, C., Arcicasa, M., Hamadou, M., Huchedé, P., Hochart, A., Restouin, A., Castellano, R., Collette, Y., Dieny, E., Vincent, A., Angrand, P.-O., Le Bourhis, X., Leblond, P., Furlan, A., Castets, M., Pasquier, E., & Meignan, S.
(2021). H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines. Cancers, 13(21), 5551.
https://doi.org/10.3390/cancers13215551